Dr. John Kuruvilla, MD
Claim this profilePrincess Margaret Cancer Centre
Area of expertise
Non-Hodgkin's Lymphoma
John Kuruvilla, MD has run 4 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Diffuse Large B-Cell Lymphoma
John Kuruvilla, MD has run 3 trials for Diffuse Large B-Cell Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Princess Margaret Cancer Centre
University Health Network
Clinical Trials John Kuruvilla, MD is currently running
Glofitamab
for Diffuse Large B-Cell Lymphoma
This is a phase ll study of participants with untreated diffuse large B Cell lymphoma (DLBCL).
Recruiting
1 award
Phase 2
9 criteria
Pembrolizumab + Bendamustine
for Hodgkin's Lymphoma
This is a phase 2 open-label study to test the safety and effectiveness of combining pembrolizumab and bendamustine in patients with relapsed (cancer that has come back or started getting worse) or refractory (cancer that is not responding or has stopped responding to treatment) Hodgkin lymphoma.
Recruiting
1 award
Phase 2
13 criteria
More about John Kuruvilla, MD
Clinical Trial Related
10 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments John Kuruvilla, MD has experience with
- Pembrolizumab
- Cyclophosphamide
- Bendamustine Hydrochloride
- Glofitamab
- CTX110
- Etoposide
Breakdown of trials John Kuruvilla, MD has run
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Kuruvilla, MD specialize in?
John Kuruvilla, MD focuses on Non-Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma. In particular, much of their work with Non-Hodgkin's Lymphoma has involved Stage IV patients, or patients who are MYC positive.
Is John Kuruvilla, MD currently recruiting for clinical trials?
Yes, John Kuruvilla, MD is currently recruiting for 5 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that John Kuruvilla, MD has studied deeply?
Yes, John Kuruvilla, MD has studied treatments such as Pembrolizumab, Cyclophosphamide, Bendamustine Hydrochloride.
What is the best way to schedule an appointment with John Kuruvilla, MD?
Apply for one of the trials that John Kuruvilla, MD is conducting.
What is the office address of John Kuruvilla, MD?
The office of John Kuruvilla, MD is located at: Princess Margaret Cancer Centre, Toronto, Ontario M5G 2M9 Canada. This is the address for their practice at the Princess Margaret Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.